Lead end-to-end clinical trial operations, ensuring compliance with GCP and regulatory standards.
Manage study start-up, regulatory submissions, TMFs, budgets, and cross-functional collaborations.
Drive risk mitigation and continuous improvement across clinical development programs.
This company is a clinical development organization focused on delivering high-quality clinical trials and advancing patient care. Its collaborative team of motivated professionals works remotely across the US with a strong emphasis on innovation and continuous improvement.
Lead operational delivery of Phase I clinical studies from start-up through close-out as the day-to-day counterpart to the CRO.
Own site relationships, drive activation readiness, and manage recruitment performance for complex dose-escalation studies.
Ensure quality and timeliness of clinical data, supplies, and vendor deliverables while maintaining ICH GCP compliance.
Numab Therapeutics is a Swiss biotech developing multi-specific antibody immunotherapies. It has a broad pipeline and completed a major J&J transaction, with Series C funding of CHF 180 million.
Lead clinical site identification, feasibility, qualification, and activation for IDE and post-market studies.
Develop and maintain relationships with investigators, coordinators, and hospital administrators to drive enrollment.
Travel 50-70% to support site development, training, and study execution across an assigned territory.
Pulse Biosciences is a bioelectric medicine company developing its proprietary CellFX nsPFA technology to non-thermally ablate tissue for treating atrial fibrillation and other conditions. The company fosters a creative, collaborative, startup-like culture focused on innovation and professional growth.